Mars CEO gets board role at GLP-1 supplier Novo Nordisk

Novo Nordisk, 1 of the main suppliers of GLP-1 weight-loss medication, has handed a committee relation to the main enforcement of Mars.

Poul Weihrauch is to beryllium a “board observer” astatine the pharma group, which markets GLP-1 drugs nether brands including Ozempic and Wegovy.

GLP-1 medication, associated with appetite suppression, was archetypal approved to dainty Type-2 diabetes successful the US much than 15 years agone and for the attraction of obesity astir a decennary ago.

However, with much consumers turning to the drugs to negociate their weight, its interaction connected purchasing behaviour is being intimately watched by the nutrient and beverage sectors. Some manufacture watchers judge the rising usage of GLP-1 medicine volition person a “structural” interaction connected the market. Research successful the US has suggested request from users for saccharine and savoury snacks has been affected.

Amid the increasing user involvement successful the drugs, nutrient and drinks manufacturers and retailers are weighing up their interaction connected their income and however to connection antithetic types of products arsenic users’ appetites change.

Asked wherefore Novo Nordisk had appointed Weihrauch to the presumption of committee observer, a spokesperson said: “We invited Poul Weihrauch to service arsenic an perceiver connected the committee to payment from his assemblage cognition and planetary enactment experience.

“As the CEO and president of Mars, Poul brings heavy commercialized penetration into multinational user markets, beardown acquisition with marque and supply‑chain strategy, and proven enactment successful driving large, analyzable organisations, each of which are highly applicable to our strategical priorities. Mars is 1 of the apical fast-moving user goods companies, and we deliberation helium volition marque a important publication to our board.”

The spokesperson declined to remark connected what Weihrauch would bash successful the role.

Weihrauch volition beryllium a Novo Nordisk committee perceiver for the 2026/2027 term. The institution plans to nominate him for predetermination arsenic a committee subordinate astatine its AGM successful 2027. The meetings usually instrumentality spot successful March.

Weihrauch joined Mars successful 2000 successful a relation moving connected the Snickers marque successful Europe. By 2011, helium was president of Mars’ planetary nutrient limb earlier becoming president of the company's pet-care concern successful 2015, a relation helium held for 7 years earlier becoming radical CEO successful 2022.

Just Food has approached Mars for comment.

"Mars CEO gets committee relation astatine GLP-1 supplier Novo Nordisk" was primitively created and published by Just Food, a GlobalData owned brand.

The accusation connected this tract has been included successful bully religion for wide informational purposes only. It is not intended to magnitude to proposal connected which you should rely, and we springiness nary representation, warranty oregon guarantee, whether explicit oregon implied arsenic to its accuracy oregon completeness. You indispensable get nonrecreational oregon specializer proposal earlier taking, oregon refraining from, immoderate enactment connected the ground of the contented connected our site.